First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

First‐ versus second‐generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta‐analysis

Published:2022-04-08 Issue:7 Volume:97 Page:942-950
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Abushukair Hassan¹^ORCID,Syaj Sebawe¹,Ababneh Obada¹^ORCID,Qarqash Aref¹,Schinke Carolina²^ORCID,Thanendrarajan Sharmilan²^ORCID,Zangari Maurizio²^ORCID,van Rhee Frits²^ORCID,Al Hadidi Samer²^ORCID

Affiliation:

1. Faculty of Medicine Jordan University of Science and Technology Irbid Jordan

2. Myeloma Center Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences Little Rock Arkansas USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26552

Reference36 articles.

1. Prognostic factors in symptomatic Waldenstrom's macroglobulinemia

2. Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management

3. DimopoulosMA TrotmanJ TedeschiA et al.Articles Ibrutinib for Patients with Rituximab‐Refractory Waldenström's Macro Globulinaemia (iNNOVATE): an Open‐Label Substudy of an International Multicentre Phase 3 Trial.2016;

4. Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-07-10

2. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

4. Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis;Blood Cancer Journal;2023-09-07

5. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management;American Journal of Hematology;2023-01